Immuno, Inc. Files Definitive Proxy Statement for 2025 Annual Meeting
Ticker: IMUX · Form: DEF 14A · Filed: Apr 22, 2025 · CIK: 1280776
| Field | Detail |
|---|---|
| Company | Immunic, INC. (IMUX) |
| Form Type | DEF 14A |
| Filed Date | Apr 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
Immuno's proxy statement is out for the June 4th meeting - vote your shares!
AI Summary
Immuno, Inc. filed its definitive proxy statement on April 22, 2025, for its annual meeting of stockholders scheduled for June 4, 2025. The filing outlines the company's governance, executive compensation, and proposals to be voted on by shareholders. Key items likely include the election of directors and ratification of auditors.
Why It Matters
This filing provides shareholders with crucial information regarding company leadership, executive pay, and voting matters, enabling informed participation in corporate governance.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) that provides information to shareholders and does not inherently represent new financial risk.
Key Numbers
- 20250422 — Filing Date (The date the definitive proxy statement was filed with the SEC.)
- 20250604 — Annual Meeting Date (The date shareholders will vote on company matters.)
Key Players & Entities
- IMMUNIC, INC. (company) — Registrant
- 20250422 (date) — Filing Date
- 20250604 (date) — Annual Meeting Date
- 001-36201 (company) — SEC File Number
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, or definitive proxy statement, is used by companies to solicit proxy votes from shareholders for their annual or special meetings.
When is IMMUNIC, INC.'s annual meeting scheduled?
The annual meeting of stockholders for IMMUNIC, INC. is scheduled for June 4, 2025.
What is the filing date of this proxy statement?
This definitive proxy statement was filed on April 22, 2025.
What is the SEC file number for IMMUNIC, INC.?
The SEC file number for IMMUNIC, INC. is 001-36201.
What is the SIC code for IMMUNIC, INC.?
The Standard Industrial Classification (SIC) code for IMMUNIC, INC. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 22, 2025 regarding IMMUNIC, INC. (IMUX).